Senior insider sale
EVP, Global Research and CSO at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$6.42M
12.98K shares
ALTSHULER DAVID plans to sell 12.98K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $6.42M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
ESPP Purchase
Cash
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/14/2025 | ESPP Purchase Cash | 52.00 | — |
| Total | 52.00 | ||
Completed
Units to sell
3.23K
Market value
$1.65M
Units to sell
3.23K
Market value
$1.62M
Units to sell
3.23K
Market value
$1.58M
Units to sell
1.27K
Market value
$610.6K
Units to sell
848.00
Market value
$407.8K
Units to sell
1.11K
Market value
$533.3K
Planned — Approximate Date
Units to sell
52.00
Market value
$22.1K
Units
12.98K
Value
$6.42M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/13/2025 | 3.23K | $1.65M | — | Completed |
3/10/2025 | 3.23K | $1.62M | — | Completed |
3/3/2025 | 3.23K | $1.58M | — | Completed |
2/27/2025 | 1.27K | $610.6K | — | Completed |
2/25/2025 | 848.00 | $407.8K | — | Completed |
2/20/2025 | 1.11K | $533.3K | — | Completed |
| Planned — Approximate Date | ||||
5/15/2025 | 52.00 | $22.1K | NASDAQ | Planned |
| Total | 12.98K | $6.42M | ||